Literature DB >> 8449951

Effects of DNA lesions on transcription elongation by T7 RNA polymerase.

Y H Chen1, D F Bogenhagen.   

Abstract

T7 phage RNA polymerase was used to transcribe a series of DNA templates bearing any of several precisely localized lesions. Lesions were positioned downstream of the T7 promoter on either strand of the DNA template to investigate the effects of these lesions on elongation of transcription. The following four types of DNA modifications were studied: 1) 3-hydroxy-2-hydroxymethyltetrahydrofuran (tetrahydrofuran), a synthetic apurinic/apyrimidinic site; 2) 8-oxoguanine (8-oxodG), an oxidized derivative of guanine; 3) N-acetyl-2-aminofluorene (AAF) modified guanine; 4) 2-aminofluorene (AF) modified guanine. None of these lesions blocked transcription elongation when they were located on the non-template strand. Lesions on the template strand blocked elongation with varied efficiency. The series of AAF-dG, AF-dG, and tetrahydrofuran lesions showed a progressively decreasing ability to block elongation, while 8-oxo-dG caused little, if any, premature termination. T7 RNA polymerase was able to read through all of the lesions with sufficient efficiency to permit chain termination sequencing using the read-through products as templates. AAF-dG and AF-dG adducts did not induce detectable misreading. Adenine and, more rarely, cytosine were incorporated opposite 8-oxo-dG, as observed for translesional synthesis by DNA polymerases. Adenine was most commonly inserted opposite the non-instructional abasic site analogue, although a minor fraction of guanine was incorporated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8449951

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest.

Authors:  Jian Xu; Francis C R Manning; Travis J O'Brien; Susan Ceryak; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

2.  3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro.

Authors:  Paola Monti; Christopher Broxson; Alberto Inga; Ruo-wen Wang; Paola Menichini; Silvia Tornaletti; Barry Gold; Gilberto Fronza
Journal:  DNA Repair (Amst)       Date:  2011-06-14

3.  Elevated mutation rate in mutT bacteria during starvation: evidence for DNA turnover?

Authors:  B A Bridges
Journal:  J Bacteriol       Date:  1996-05       Impact factor: 3.490

4.  Archaeal RNA polymerase arrests transcription at DNA lesions.

Authors:  Alexandra M Gehring; Thomas J Santangelo
Journal:  Transcription       Date:  2017-06-09

Review 5.  Transcriptional mutagenesis: causes and involvement in tumour development.

Authors:  Damien Brégeon; Paul W Doetsch
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

Review 6.  Mechanisms of transcription-repair coupling and mutation frequency decline.

Authors:  C P Selby; A Sancar
Journal:  Microbiol Rev       Date:  1994-09

7.  DNA damage-induced ATM- and Rad-3-related (ATR) kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor IIH (TFIIH).

Authors:  Michael G Kemp
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

8.  Transcription blockage by bulky end termini at single-strand breaks in the DNA template: differential effects of 5' and 3' adducts.

Authors:  Alexander J Neil; Boris P Belotserkovskii; Philip C Hanawalt
Journal:  Biochemistry       Date:  2012-10-24       Impact factor: 3.162

9.  RNA polymerase bypass at sites of dihydrouracil: implications for transcriptional mutagenesis.

Authors:  J Liu; W Zhou; P W Doetsch
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

10.  Molecular basis of transcriptional mutagenesis at 8-oxoguanine.

Authors:  Gerke E Damsma; Patrick Cramer
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.